Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis

NCT02205762 is registered in ClinicalTrials.gov with North American Consortium for Histiocytosis as lead sponsor.

NCT NCT02205762
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02205762 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
Lead sponsor
North American Consortium for Histiocytosis
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
November 2, 2016
Completion date
July 31, 2026
Enrollment
1,400 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

langerhans cell histiocytosis